Closes gaps in deal-structure antitrust risk analysis including hell-or-high-water provision adequacy, reverse termination fee sufficiency, outside date feasibility, and hot-document identification.
Scanned 9/11/2026
Install to Claude Code
npx -y skills add sunyifeisb-art/legalwork --skill analyze-iss-antitrust-transaction-structure --agent claude-codeInstalls into .claude/skills of the current project.
Are you the author of Analyze Iss Antitrust Transaction Structure?
Add the live security badge to your README — it updates automatically with every re-scan.
[](https://www.skillsdirectory.com/skills/sunyifeisb-art-analyze-iss-antitrust-transaction-structure)More formats (shields.io, HTML) on the badges page.
---
name: analyze-iss-antitrust-transaction-structure
task_id: antitrust-competition/analyze-iss-antitrust-transaction-structure
description: Closes gaps in deal-structure antitrust risk analysis including hell-or-high-water provision adequacy, reverse termination fee sufficiency, outside date feasibility, and hot-document identification.
activates_for: [planner, solver, checker]
---
# Skill: Antitrust Transaction Structure Analysis
## 1. Subject-matter triage
- Treat the assignment as an antitrust deal-review memo, not a generic diligence summary.
- Identify whether the source set includes merger agreement drafts, board decks, banker materials, emails, schedules, and regulatory strategy materials.
- Separate transactional structure issues from substantive competition issues, then connect them back to clearance risk and closing mechanics.
- If multiple jurisdictions, business lines, or product overlaps are present, analyze each as a distinct clearance track rather than collapsing them into one global assessment.
## 2. Failure modes the skill is correcting
- The analysis stops at “antitrust risk exists” without tying that risk to a specific remedy posture, filing path, or closing consequence.
- The analysis ignores the practical force of a reverse termination fee and whether it is large enough to change behavior rather than merely allocate downside.
- The analysis treats a divestiture cap, remedy carve-out, or consent limitation as boilerplate instead of testing whether it weakens the buyer’s clearance commitment.
- The analysis misses whether the outside date leaves enough runway for clearance review, second requests, remedy negotiation, or post-clearance waiting periods.
- The analysis overlooks internal materials that frame the deal as a pricing, capacity, market-power, or competitor-removal story and therefore require careful document handling.
- The analysis mentions overlap but does not connect overlap to likely unilateral, coordinated, or vertical theories of harm.
- The analysis identifies concerns but does not end with concrete recommendations on filings, term changes, preservation, and remedy strategy.
## 3. Legal frameworks / domain conventions that apply
- Use the relevant merger-control standard for each jurisdiction implicated by the deal; anchor the analysis in the governing competition statute and agency practice for that forum.
- For U.S. review, frame the substantive analysis under Section 7 of the Clayton Act and the Hart-Scott-Rodino Act filing regime where applicable; for other jurisdictions, use the local merger-control statute and clearance test.
- Assess concentration, overlap, and competitive effects using the standard merger-screen framework: relevant market, shares, concentration, entry, diversion, and likely remedy path.
- Treat a hell-or-high-water commitment as meaningful only if it obligates the buyer to pursue and accept commercially reasonable remedies needed for clearance; remedy caps, asset exclusions, or “no structural divestiture” language may materially dilute it.
- Evaluate a reverse termination fee as an incentive device: it should be measured against the transaction’s risk profile and closing economics, not treated as sufficient merely because it exists.
- Test the outside date against expected agency timing, second-request exposure, litigation risk, and any post-clearance waiting period or local sequencing requirement.
- Treat internal documents discussing pricing power, reduced competition, market control, customer capture, or competitor removal as hot documents relevant to intent and effects.
- Treat non-compete and similar retention restrictions as part of the competition analysis where departing personnel or management could compete post-closing.
- Use merger-specific remedy concepts: divestiture buyer viability, fix-it-first feasibility, conduct remedy limits, and whether the proposed buyer restores competitive conditions.
## 4. Analytical scaffolds
1. Map the transaction
- Identify the parties, business lines, products, geography, and review jurisdictions.
- Enumerate each overlap, adjacency, and customer-facing interaction before analyzing effects.
2. Assess substantive antitrust risk
- Define the likely relevant market(s) at the level supported by the documents.
- Analyze concentration, diversion, customer switching, capacity, and entry.
- State the likely theory of harm for each overlap: unilateral effects, coordinated effects, foreclosure, or information-based concerns.
3. Test the documentary record for hot issues
- Review board decks, banker books, management presentations, emails, and draft strategy materials for competition-sensitive language.
- Flag each item by document type and why it is sensitive.
- Recommend preservation, legal hold, and privilege review steps where the record suggests antitrust intent risk.
4. Analyze deal-protection mechanics
- Evaluate whether the hell-or-high-water covenant is broad enough to require meaningful remedy pursuit.
- Check whether any remedy cap, carve-out, or buyer consent right undermines the covenant.
- Assess whether the reverse termination fee is large enough to create real clearance incentives.
- Test whether the outside date accommodates the likely clearance path.
5. Evaluate remedies and filing strategy
- Identify whether divestiture, conduct commitments, or behavioral undertakings are likely to be requested.
- Assess potential remedy buyers for capability, independence, and operational fit.
- Determine whether filings should be made early, simultaneously, sequentially, or with a hold-separate strategy.
6. Close each issue with consequences
- For every issue, tie the concern to a source-document metric or transactional fact, cross-reference the clause or exhibit that affects it, and state the closing, regulatory, or litigation consequence.
7. Assign severity consistently
- Use a defined ordinal severity scale throughout the memo and apply it uniformly to each issue.
## 5. Vertical / structural / temporal relationships
- Identify how the merger agreement, disclosure schedules, internal strategy materials, and regulatory communications interact.
- If one provision limits another, explain the hierarchy in practical terms: e.g., a remedy covenant may be narrowed by a cap, timing gate, or consent standard.
- Track sequencing risk: signing, filing, waiting period, second request, remedy discussions, and closing should be analyzed in temporal order.
- If the record contains multiple products, regions, or clearance authorities, analyze them separately first and then state the combined closing timetable.
- Distinguish pre-signing risk flags from post-signing obligations so the memo does not conflate diligence concerns with covenants.
## 6. Output structure conventions
- Begin with a short executive summary stating the overall antitrust risk level and the likely clearance posture.
- Use a clear severity scale near the front of the memo and apply it to each issue consistently.
- Organize the body in a conventional issues-memo shape:
- Transaction overview and review scope
- Competitive overlap and market context
- Hot documents and document-handling risks
- Deal-protection and closing-condition analysis
- Remedies and filing strategy
- Recommended actions
- For each issue, include:
- Severity
- Legal basis with the controlling authority named
- The relevant factual trigger from the documents
- The interaction with another clause, schedule, or document
- The downstream consequence for clearance, timing, or economics
- Do not state antitrust conclusions in conclusory form without naming the governing statute, regulation, or doctrinal standard supporting them.
- End with a Recommended Actions block that assigns each action to a responsible role and ties it to a transaction or regulatory milestone.
- Include document-preservation and privilege-review steps whenever internal materials suggest competition-sensitive intent.
- If the source set supports more than one filing path or remedy posture, list each path separately and compare the tradeoffs rather than selecting a single default.
Is this your skill, or is something wrong with this listing? Request removal or report an issue. Author removals are honored within 72 hours.
No comments yet. Be the first to comment!